Brief: Nurexone Announces Binding MoU With Made Scientific For U.S. Gmp Manufacturing And Commercial Supply Partnership
12/08/2026 22:49
BRIEF-Nurexone Announces Binding MoU With Made Scientific For U.S. Gmp Manufacturing And Commercial Supply Partnership Aug 12 (Reuters) - Nurexone Biologic Inc NRX.V:
NUREXONE ANNOUNCES BINDING MOU WITH MADE SCIENTIFIC FOR U.S. GMP MANUFACTURING AND COMMERCIAL SUPPLY PARTNERSHIP
NUREXONE BIOLOGIC -UNIT SIGNS BINDING MOU WITH MADE SCIENTIFIC FOR EXCLUSIVE U.S. GMP MANUFACTURING PARTNERSHIP
NUREXONE BIOLOGIC - TARGETS FIRST GMP EXOSOME BATCHES IN H1 2027
NUREXONE BIOLOGIC - DEFINITIVE AGREEMENT TO HAVE INITIAL FIVE-YEAR TERM WITH FIVE-YEAR RENEWAL OPTIONS
Source text: ID:nGNX4WGmYg
Further company coverage: NRX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nurexone Biologic
See all newsBrief: Nurexone Announces Binding MoU With Made Scientific For U.S. Gmp Manufacturing And Commercial Supply Partnership
Brief: Corporate Updates – Nurexone Appoints Mr. David Stolick To The Board Of Directors
Brief: Exo-Top, Nurexone’S Wholly Owned U.S. Subsidiary, Enters Into Binding MoU For Naïve Exosome Distribution In Mexico
Brief: Nurexone Biologic’S U.S. Subsidiary Exo-Top And Florida-Based Bioxtek Sign Strategic Loi For Exosome Manufacturing And Commercialization
Brief: Nurexone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement